サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1558609

月経用医薬品の世界市場、2024～2028年

Global Menstrual Drugs Market 2024-2028

出版日
発行
TechNavio
ページ情報
英文 220 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
月経用医薬品の世界市場、2024～2028年
出版日: 2024年08月24日
発行: TechNavio
ページ情報: 英文 220 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

月経用医薬品市場、2024～2028年

月経用医薬品市場は2023～2028年に36億1,940万米ドル、予測期間中のCAGRは7.75%で成長すると予測されます。当レポートでは、月経用医薬品市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、月経の健康に関する女性の教育重視の高まり、月経障害の有病率の上昇、経済成長と可処分所得の増加によって牽引されています。

市場範囲
基準年 2024年
終了年 2028年
予測期間 2024～2028年
成長モメンタム 加速
前年比[2024年] 7.31%
CAGR 7.75%
増分額 36億1,940万米ドル

本調査では、今後数年間の月経用医薬品市場の成長を牽引する主要要因の1つとして、薬剤療法の人気の高まりを挙げています。また、ドラッグデリバリー手法の革新や個別化医療の採用が進むことで、同市場には大きな需要が見込まれます。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023年
  • 市場の展望 2023～2028年

第5章 市場規模実績

  • 月経用医薬品の世界市場 2018～2022年
  • タイプ別セグメント分析 2018～2022年
  • 投与経路別セグメント分析 2018～2022年
  • 地域別セグメント分析 2018～2022年
  • 国別セグメント分析 2018～2022年

第6章 定性分析

  • AIの影響月経用医薬品の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：タイプ別

  • 市場セグメンテーション
  • 比較：タイプ別
  • ホルモン治療：市場規模と予測 2023～2028年
  • 鎮痛薬：市場規模と予測 2023～2028年
  • PMSとPMDD薬：市場規模と予測 2023～2028年
  • 月経調節薬：市場規模と予測 2023～2028年
  • 子宮内膜症治療：市場規模と予測 2023～2028年
  • 市場機会：タイプ別

第9章 市場セグメンテーション：投与経路別

  • 市場セグメンテーション
  • 比較：投与経路別
  • 経口：市場規模と予測 2023～2028年
  • 注射：市場規模と予測 2023～2028年
  • 局所：市場規模と予測 2023～2028年
  • 市場機会：投与経路別

第10章 顧客情勢

  • 顧客情勢概要

第11章 地域別情勢

  • 地域別セグメンテーション
  • 比較：地域別
  • 北米：市場規模と予測 2023～2028年
  • 欧州：市場規模と予測 2023～2028年
  • アジア：市場規模と予測 2023～2028年
  • その他：市場規模と予測 2023～2028年
  • 米国：市場規模と予測 2023～2028年
  • 中国：市場規模と予測 2023～2028年
  • インド：市場規模と予測 2023～2028年
  • ドイツ：市場規模と予測 2023～2028年
  • 英国：市場規模と予測 2023～2028年
  • フランス：市場規模と予測 2023～2028年
  • 日本：市場規模と予測 2023～2028年
  • カナダ：市場規模と予測 2023～2028年
  • 韓国：市場規模と予測 2023～2028年
  • ブラジル：市場規模と予測 2023～2028年
  • 市場機会：地域情勢別

第12章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第13章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第14章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • AbbVie Inc.
  • Adorefem
  • Bayer AG
  • Cipla Inc.
  • Dr Reddys Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Haleon Plc
  • Johnson and Johnson Services Inc.
  • Mallinckrodt Plc
  • Maxwellia Ltd.
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Lifesciences Ltd.

第15章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits11: Overview on criticality of inputs and factors of differentiation
  • Exhibits12: Overview on factors of disruption
  • Exhibits13: Impact of drivers and challenges in 2023 and 2028
  • Exhibits14: Parent Market
  • Exhibits15: Data Table on - Parent Market
  • Exhibits16: Market characteristics analysis
  • Exhibits17: Value Chain Analysis
  • Exhibits18: Offerings of companies included in the market definition
  • Exhibits19: Market segments
  • Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits24: Historic Market Size - Data Table on Global Menstrual Drugs Market 2018 - 2022 ($ million)
  • Exhibits25: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits26: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
  • Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits29: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits35: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits36: Chart on Type - Market share 2023-2028 (%)
  • Exhibits37: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits38: Chart on Comparison by Type
  • Exhibits39: Data Table on Comparison by Type
  • Exhibits40: Chart on Hormonal treatments - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Hormonal treatments - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Hormonal treatments - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Hormonal treatments - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Pain relief medications - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on Pain relief medications - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on Pain relief medications - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Pain relief medications - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on PMS and PMDD medications - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on PMS and PMDD medications - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on PMS and PMDD medications - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on PMS and PMDD medications - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Menstrual regulation drugs - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Menstrual regulation drugs - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Menstrual regulation drugs - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Menstrual regulation drugs - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Endometriosis treatments - Market size and forecast 2023-2028 ($ million)
  • Exhibits57: Data Table on Endometriosis treatments - Market size and forecast 2023-2028 ($ million)
  • Exhibits58: Chart on Endometriosis treatments - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Endometriosis treatments - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Market opportunity by Type ($ million)
  • Exhibits61: Data Table on Market opportunity by Type ($ million)
  • Exhibits62: Chart on Route of Administration - Market share 2023-2028 (%)
  • Exhibits63: Data Table on Route of Administration - Market share 2023-2028 (%)
  • Exhibits64: Chart on Comparison by Route of Administration
  • Exhibits65: Data Table on Comparison by Route of Administration
  • Exhibits66: Chart on Oral medications - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Data Table on Oral medications - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Chart on Oral medications - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Data Table on Oral medications - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Chart on Injectables - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Chart on Topical applications - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Data Table on Topical applications - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Chart on Topical applications - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Data Table on Topical applications - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Market opportunity by Route of Administration ($ million)
  • Exhibits79: Data Table on Market opportunity by Route of Administration ($ million)
  • Exhibits80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits81: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits83: Chart on Geographic comparison
  • Exhibits84: Data Table on Geographic comparison
  • Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits110: Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits111: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on India - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits114: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits115: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits118: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits119: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits120: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits121: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits122: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits123: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits124: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits125: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits126: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits127: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits128: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits129: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits130: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits131: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits132: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits133: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
  • Exhibits134: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
  • Exhibits135: Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits136: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits137: Chart on Brazil - Market size and forecast 2023-2028 ($ million)
  • Exhibits138: Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
  • Exhibits139: Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Exhibits140: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • Exhibits141: Market opportunity By Geographical Landscape ($ million)
  • Exhibits142: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits143: Impact of drivers and challenges in 2023 and 2028
  • Exhibits144: Overview on criticality of inputs and factors of differentiation
  • Exhibits145: Overview on factors of disruption
  • Exhibits146: Impact of key risks on business
  • Exhibits147: Companies covered
  • Exhibits148: Company ranking index
  • Exhibits149: Matrix on companies position and classification
  • Exhibits150: AbbVie Inc. - Overview
  • Exhibits151: AbbVie Inc. - Product / Service
  • Exhibits152: AbbVie Inc. - Key news
  • Exhibits153: AbbVie Inc. - Key offerings
  • Exhibits154: SWOT
  • Exhibits155: Adorefem - Overview
  • Exhibits156: Adorefem - Product / Service
  • Exhibits157: Adorefem - Key offerings
  • Exhibits158: SWOT
  • Exhibits159: Bayer AG - Overview
  • Exhibits160: Bayer AG - Business segments
  • Exhibits161: Bayer AG - Key news
  • Exhibits162: Bayer AG - Key offerings
  • Exhibits163: Bayer AG - Segment focus
  • Exhibits164: SWOT
  • Exhibits165: Cipla Inc. - Overview
  • Exhibits166: Cipla Inc. - Business segments
  • Exhibits167: Cipla Inc. - Key news
  • Exhibits168: Cipla Inc. - Key offerings
  • Exhibits169: Cipla Inc. - Segment focus
  • Exhibits170: SWOT
  • Exhibits171: Dr Reddys Laboratories Ltd. - Overview
  • Exhibits172: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibits173: Dr Reddys Laboratories Ltd. - Key news
  • Exhibits174: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibits175: Dr Reddys Laboratories Ltd. - Segment focus
  • Exhibits176: SWOT
  • Exhibits177: GlaxoSmithKline Plc - Overview
  • Exhibits178: GlaxoSmithKline Plc - Business segments
  • Exhibits179: GlaxoSmithKline Plc - Key news
  • Exhibits180: GlaxoSmithKline Plc - Key offerings
  • Exhibits181: GlaxoSmithKline Plc - Segment focus
  • Exhibits182: SWOT
  • Exhibits183: Haleon Plc - Overview
  • Exhibits184: Haleon Plc - Business segments
  • Exhibits185: Haleon Plc - Key offerings
  • Exhibits186: Haleon Plc - Segment focus
  • Exhibits187: SWOT
  • Exhibits188: Johnson and Johnson Services Inc. - Overview
  • Exhibits189: Johnson and Johnson Services Inc. - Business segments
  • Exhibits190: Johnson and Johnson Services Inc. - Key news
  • Exhibits191: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits192: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits193: SWOT
  • Exhibits194: Mallinckrodt Plc - Overview
  • Exhibits195: Mallinckrodt Plc - Business segments
  • Exhibits196: Mallinckrodt Plc - Key news
  • Exhibits197: Mallinckrodt Plc - Key offerings
  • Exhibits198: Mallinckrodt Plc - Segment focus
  • Exhibits199: SWOT
  • Exhibits200: Maxwellia Ltd. - Overview
  • Exhibits201: Maxwellia Ltd. - Product / Service
  • Exhibits202: Maxwellia Ltd. - Key offerings
  • Exhibits203: SWOT
  • Exhibits204: Perrigo Co. Plc - Overview
  • Exhibits205: Perrigo Co. Plc - Business segments
  • Exhibits206: Perrigo Co. Plc - Key news
  • Exhibits207: Perrigo Co. Plc - Key offerings
  • Exhibits208: Perrigo Co. Plc - Segment focus
  • Exhibits209: SWOT
  • Exhibits210: Pfizer Inc. - Overview
  • Exhibits211: Pfizer Inc. - Product / Service
  • Exhibits212: Pfizer Inc. - Key news
  • Exhibits213: Pfizer Inc. - Key offerings
  • Exhibits214: SWOT
  • Exhibits215: Sanofi SA - Overview
  • Exhibits216: Sanofi SA - Business segments
  • Exhibits217: Sanofi SA - Key news
  • Exhibits218: Sanofi SA - Key offerings
  • Exhibits219: Sanofi SA - Segment focus
  • Exhibits220: SWOT
  • Exhibits221: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits222: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits223: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits224: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits225: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits226: SWOT
  • Exhibits227: Zydus Lifesciences Ltd. - Overview
  • Exhibits228: Zydus Lifesciences Ltd. - Business segments
  • Exhibits229: Zydus Lifesciences Ltd. - Key news
  • Exhibits230: Zydus Lifesciences Ltd. - Key offerings
  • Exhibits231: Zydus Lifesciences Ltd. - Segment focus
  • Exhibits232: SWOT
  • Exhibits233: Inclusions checklist
  • Exhibits234: Exclusions checklist
  • Exhibits235: Currency conversion rates for US$
  • Exhibits236: Research methodology
  • Exhibits237: Information sources
  • Exhibits238: Data validation
  • Exhibits239: Validation techniques employed for market sizing
  • Exhibits240: Data synthesis
  • Exhibits241: 360 degree market analysis
  • Exhibits242: List of abbreviations
目次
Product Code: IRTNTR80128

Menstrual Drugs Market 2024-2028

The menstrual drugs market is forecasted to grow by USD 3619.4 mn during 2023-2028, accelerating at a CAGR of 7.75% during the forecast period. The report on the menstrual drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing emphasis on educating women about menstrual health, rising prevalence of menstrual disorders, and economic growth and rising disposable incomes.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.31%
CAGR7.75%
Incremental Value$3619.4 mn

Technavio's menstrual drugs market is segmented as below:

By Type

    • Hormonal treatments
    • Pain relief medications
    • PMS and PMDD medications
    • Menstrual regulation drugs
    • Endometriosis treatments

By Route Of Administration

    • Oral medications
    • Injectables
    • Topical applications

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the increase in popularity of drug therapy as one of the prime reasons driving the menstrual drugs market growth during the next few years. Also, innovation in drug delivery methods and rising adoption of personalized medicine will lead to sizable demand in the market.

The report on the menstrual drugs market covers the following areas:

    • Menstrual drugs market sizing
    • Menstrual drugs market forecast
    • Menstrual drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading menstrual drugs market vendors that include AbbVie Inc., Adorefem, Bayer AG, Cipla Inc., DR Reddys Laboratories Ltd., GlaxoSmithKline PLC, Haleon PLC, Himalaya Wellness Co., Johnson and Johnson Services Inc., Leeford Healthcare Ltd., Mallinckrodt PLC, Maxwellia Ltd., Perrigo Co. PLC, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi SA, SteriMax Inc., Sumitomo Chemical Co. Ltd., Teva Pharmaceutical Industries Ltd., Walgreens Boots Alliance Inc., and Zydus Lifesciences Ltd.. Also, the menstrual drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value Chain Analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2023
  • 4.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

  • 5.1 Global Menstrual Drugs Market 2018 - 2022
    • Historic Market Size - Data Table on Global Menstrual Drugs Market 2018 - 2022 ($ million)
  • 5.2 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 5.3 Route of Administration segment analysis 2018 - 2022
    • Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
  • 5.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 5.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI in the Global Menstrual Drugs Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

  • 8.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 8.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 8.3 Hormonal treatments - Market size and forecast 2023-2028
    • Chart on Hormonal treatments - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hormonal treatments - Market size and forecast 2023-2028 ($ million)
    • Chart on Hormonal treatments - Year-over-year growth 2023-2028 (%)
    • Data Table on Hormonal treatments - Year-over-year growth 2023-2028 (%)
  • 8.4 Pain relief medications - Market size and forecast 2023-2028
    • Chart on Pain relief medications - Market size and forecast 2023-2028 ($ million)
    • Data Table on Pain relief medications - Market size and forecast 2023-2028 ($ million)
    • Chart on Pain relief medications - Year-over-year growth 2023-2028 (%)
    • Data Table on Pain relief medications - Year-over-year growth 2023-2028 (%)
  • 8.5 PMS and PMDD medications - Market size and forecast 2023-2028
    • Chart on PMS and PMDD medications - Market size and forecast 2023-2028 ($ million)
    • Data Table on PMS and PMDD medications - Market size and forecast 2023-2028 ($ million)
    • Chart on PMS and PMDD medications - Year-over-year growth 2023-2028 (%)
    • Data Table on PMS and PMDD medications - Year-over-year growth 2023-2028 (%)
  • 8.6 Menstrual regulation drugs - Market size and forecast 2023-2028
    • Chart on Menstrual regulation drugs - Market size and forecast 2023-2028 ($ million)
    • Data Table on Menstrual regulation drugs - Market size and forecast 2023-2028 ($ million)
    • Chart on Menstrual regulation drugs - Year-over-year growth 2023-2028 (%)
    • Data Table on Menstrual regulation drugs - Year-over-year growth 2023-2028 (%)
  • 8.7 Endometriosis treatments - Market size and forecast 2023-2028
    • Chart on Endometriosis treatments - Market size and forecast 2023-2028 ($ million)
    • Data Table on Endometriosis treatments - Market size and forecast 2023-2028 ($ million)
    • Chart on Endometriosis treatments - Year-over-year growth 2023-2028 (%)
    • Data Table on Endometriosis treatments - Year-over-year growth 2023-2028 (%)
  • 8.8 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Route of Administration

  • 9.1 Market segments
    • Chart on Route of Administration - Market share 2023-2028 (%)
    • Data Table on Route of Administration - Market share 2023-2028 (%)
  • 9.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 9.3 Oral medications - Market size and forecast 2023-2028
    • Chart on Oral medications - Market size and forecast 2023-2028 ($ million)
    • Data Table on Oral medications - Market size and forecast 2023-2028 ($ million)
    • Chart on Oral medications - Year-over-year growth 2023-2028 (%)
    • Data Table on Oral medications - Year-over-year growth 2023-2028 (%)
  • 9.4 Injectables - Market size and forecast 2023-2028
    • Chart on Injectables - Market size and forecast 2023-2028 ($ million)
    • Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
    • Chart on Injectables - Year-over-year growth 2023-2028 (%)
    • Data Table on Injectables - Year-over-year growth 2023-2028 (%)
  • 9.5 Topical applications - Market size and forecast 2023-2028
    • Chart on Topical applications - Market size and forecast 2023-2028 ($ million)
    • Data Table on Topical applications - Market size and forecast 2023-2028 ($ million)
    • Chart on Topical applications - Year-over-year growth 2023-2028 (%)
    • Data Table on Topical applications - Year-over-year growth 2023-2028 (%)
  • 9.6 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ million)
    • Data Table on Market opportunity by Route of Administration ($ million)

10 Customer Landscape

  • 10.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

  • 11.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 11.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 11.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 11.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 11.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 11.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 11.8 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 11.9 India - Market size and forecast 2023-2028
    • Chart on India - Market size and forecast 2023-2028 ($ million)
    • Data Table on India - Market size and forecast 2023-2028 ($ million)
    • Chart on India - Year-over-year growth 2023-2028 (%)
    • Data Table on India - Year-over-year growth 2023-2028 (%)
  • 11.10 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 11.11 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 11.12 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ million)
    • Data Table on France - Market size and forecast 2023-2028 ($ million)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 11.13 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 11.14 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 11.15 South Korea - Market size and forecast 2023-2028
    • Chart on South Korea - Market size and forecast 2023-2028 ($ million)
    • Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
    • Chart on South Korea - Year-over-year growth 2023-2028 (%)
    • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • 11.16 Brazil - Market size and forecast 2023-2028
    • Chart on Brazil - Market size and forecast 2023-2028 ($ million)
    • Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
    • Chart on Brazil - Year-over-year growth 2023-2028 (%)
    • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • 11.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

  • 12.1 Market drivers
  • 12.2 Market challenges
  • 12.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 12.4 Market opportunities/restraints

13 Competitive Landscape

  • 13.1 Overview
  • 13.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 13.3 Landscape disruption
    • Overview on factors of disruption
  • 13.4 Industry risks
    • Impact of key risks on business

14 Competitive Analysis

  • 14.1 Companies profiled
    • Companies covered
  • 14.2 Company ranking index
    • Company ranking index
  • 14.3 Market positioning of companies
    • Matrix on companies position and classification
  • 14.4 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 14.5 Adorefem
    • Adorefem - Overview
    • Adorefem - Product / Service
    • Adorefem - Key offerings
    • SWOT
  • 14.6 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 14.7 Cipla Inc.
    • Cipla Inc. - Overview
    • Cipla Inc. - Business segments
    • Cipla Inc. - Key news
    • Cipla Inc. - Key offerings
    • Cipla Inc. - Segment focus
    • SWOT
  • 14.8 Dr Reddys Laboratories Ltd.
    • Dr Reddys Laboratories Ltd. - Overview
    • Dr Reddys Laboratories Ltd. - Business segments
    • Dr Reddys Laboratories Ltd. - Key news
    • Dr Reddys Laboratories Ltd. - Key offerings
    • Dr Reddys Laboratories Ltd. - Segment focus
    • SWOT
  • 14.9 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 14.10 Haleon Plc
    • Haleon Plc - Overview
    • Haleon Plc - Business segments
    • Haleon Plc - Key offerings
    • Haleon Plc - Segment focus
    • SWOT
  • 14.11 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
    • SWOT
  • 14.12 Mallinckrodt Plc
    • Mallinckrodt Plc - Overview
    • Mallinckrodt Plc - Business segments
    • Mallinckrodt Plc - Key news
    • Mallinckrodt Plc - Key offerings
    • Mallinckrodt Plc - Segment focus
    • SWOT
  • 14.13 Maxwellia Ltd.
    • Maxwellia Ltd. - Overview
    • Maxwellia Ltd. - Product / Service
    • Maxwellia Ltd. - Key offerings
    • SWOT
  • 14.14 Perrigo Co. Plc
    • Perrigo Co. Plc - Overview
    • Perrigo Co. Plc - Business segments
    • Perrigo Co. Plc - Key news
    • Perrigo Co. Plc - Key offerings
    • Perrigo Co. Plc - Segment focus
    • SWOT
  • 14.15 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 14.16 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 14.17 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
    • SWOT
  • 14.18 Zydus Lifesciences Ltd.
    • Zydus Lifesciences Ltd. - Overview
    • Zydus Lifesciences Ltd. - Business segments
    • Zydus Lifesciences Ltd. - Key news
    • Zydus Lifesciences Ltd. - Key offerings
    • Zydus Lifesciences Ltd. - Segment focus
    • SWOT

15 Appendix

  • 15.1 Scope of the report
  • 15.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 15.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 15.4 Research methodology
    • Research methodology
  • 15.5 Data procurement
    • Information sources
  • 15.6 Data validation
    • Data validation
  • 15.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 15.8 Data synthesis
    • Data synthesis
  • 15.9 360 degree market analysis
    • 360 degree market analysis
  • 15.10 List of abbreviations
    • List of abbreviations